Related Experiment Video
Updated: Oct 17, 2025

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Negative Impact Factors in HIV-Tuberculosis.
Ana-Maria Zaharie1, Mirela Tigau1
1Marius Nasta Institute of Pneumology, 4th District TB Unit, Bucharest, Romania.
Tuberculosis treatment outcomes are poorer in people with HIV coinfection. Intravenous drug use and homelessness were associated with poor outcomes in HIV-TB patients, necessitating targeted interventions.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis (TB) is a leading infectious cause of death in people living with HIV (HIV-TB coinfection).
- TB treatment outcomes are generally poorer in patients coinfected with HIV.
- This study aimed to identify factors associated with poor TB treatment outcomes in HIV-TB coinfected individuals.
Discussion:
- Retrospective cohort study analyzing data from a local TB registry (2009-2016).
- Included 86 patients with HIV-TB coinfection, with a mean age of 35.05 years.
- Key patient characteristics included high rates of drug use (51.16%) and homelessness (22.10%).
Key Insights:
- Treatment success was achieved in 63.95% of cases; 22.09% died.
- Univariate analysis identified drug use, homelessness, and viral hepatitis as factors associated with poor outcomes.
- Multivariate analysis showed marginal significance for homelessness and drug use, suggesting complex interactions.
Outlook:
- Patients with HIV-TB coinfection, particularly intravenous drug users and those experiencing homelessness, require focused attention.
- Dedicated programs are essential to improve treatment success rates and reduce mortality in this vulnerable population.
- Further research may elucidate specific interventions to mitigate the impact of these risk factors.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
07:39An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sexually Transmitted Infections
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...